NAUT Filings — Nautilus Biotechnology, Inc.

FilingSpy

NAUT Filings — Nautilus Biotechnology, Inc. - FilingSpy

Insiders trading · 6M

1 selling · 1 buying

Bought · 6M

25.0K

1 open-market buys

Sold · 6M

5.00M

2 open-market sales

Own-timing sales

5.00M

of 5.00M sold

Insiders

Ranked by how much each holding moved in the last 6 months

Patel Sujal MCEO, President, and Secretary, Director, 10% owner · 1 transaction

17.46M+0.1%

Bought 25.0K

Andreessen Marc L +5 co-filers10% owner · 2 transactions

12.65M—

Sold 5.00M

Insider	Stake change	Holds now	Granted / vested	Bought	Sold
Patel Sujal MCEO, President, and Secretary, Director, 10% owner · 1 transaction	+0.1%	17.46M	—	25.0K	—
Andreessen Marc L +5 co-filers10% owner · 2 transactions	—	12.65M	—	—	5.00M

Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.

Net open-market activity over the last 6 months: -4.97M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.